{
    "2018-10-11": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Investor Insights: Teva Pharmaceutical’s Valuation Multiples",
                "features": {
                    "keywords": [
                        "Teva",
                        "Valuation",
                        "Multiples"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Noteworthy Thursday Option Activity: MAR, LLY, FIT",
                "features": {
                    "keywords": [
                        "Option Activity",
                        "MAR",
                        "LLY",
                        "FIT"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diverse"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-08",
                "original_text": "Incyte's Jakafi Demand Strong, Label Expansion to Boost Sales",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Jakafi",
                        "Demand",
                        "Label Expansion",
                        "Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-20",
                "original_text": "Here’s why you should expect more ‘beats’ during this earnings season",
                "features": {
                    "keywords": [
                        "Earnings Season",
                        "Beats"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}